Willy Weng

1.0k total citations
17 papers, 544 citations indexed

About

Willy Weng is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Physiology. According to data from OpenAlex, Willy Weng has authored 17 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Physiology. Recurrent topics in Willy Weng's work include Cardiac Arrhythmias and Treatments (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Cardiac pacing and defibrillation studies (4 papers). Willy Weng is often cited by papers focused on Cardiac Arrhythmias and Treatments (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Cardiac pacing and defibrillation studies (4 papers). Willy Weng collaborates with scholars based in Canada, United States and Brazil. Willy Weng's co-authors include Udaya S. Tantry, Kevin P. Bliden, Tania Gesheff, Paul A. Gurbel, Nagaraj K. Neerchal, Joseph DiChiara, Thomas A. Lagace, Rodrigo B. Cavalcanti, David H. Birnie and Pablo B. Nery and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Willy Weng

16 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Willy Weng Canada 8 354 237 114 109 55 17 544
Rosa Coppolecchia United States 3 382 1.1× 183 0.8× 121 1.1× 67 0.6× 79 1.4× 5 525
David R. Lowry United States 12 531 1.5× 242 1.0× 60 0.5× 97 0.9× 54 1.0× 17 671
Laurent Macchi France 12 438 1.2× 205 0.9× 195 1.7× 183 1.7× 63 1.1× 30 682
Claudia Saracini Italy 12 446 1.3× 262 1.1× 149 1.3× 76 0.7× 133 2.4× 20 673
Ilaria Sestini Italy 10 413 1.2× 254 1.1× 134 1.2× 62 0.6× 126 2.3× 14 653
Nicolas Vignolles France 11 557 1.6× 293 1.2× 53 0.5× 150 1.4× 143 2.6× 13 744
C. M. Hackeng Netherlands 15 702 2.0× 352 1.5× 136 1.2× 199 1.8× 155 2.8× 28 876
Riitta Lassila Finland 9 210 0.6× 81 0.3× 92 0.8× 72 0.7× 79 1.4× 12 351
Simon Kouz Canada 13 436 1.2× 254 1.1× 28 0.2× 63 0.6× 61 1.1× 34 710
Geneviève Le Calvez France 8 604 1.7× 271 1.1× 155 1.4× 125 1.1× 105 1.9× 14 905

Countries citing papers authored by Willy Weng

Since Specialization
Citations

This map shows the geographic impact of Willy Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willy Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willy Weng more than expected).

Fields of papers citing papers by Willy Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willy Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willy Weng. The network helps show where Willy Weng may publish in the future.

Co-authorship network of co-authors of Willy Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Willy Weng. A scholar is included among the top collaborators of Willy Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willy Weng. Willy Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Murray, Brian C., Mehrdad Golian, Mouhannad M. Sadek, et al.. (2025). Effectiveness of a Standardized Approach to Repeat Paroxysmal Atrial Fibrillation Ablation: Insights Into the Value of Extrapulmonary Vein Targets. Canadian Journal of Cardiology. 41(7). 1319–1326. 1 indexed citations
2.
Weng, Willy, Anahita Tavoosi, Pablo B. Nery, et al.. (2023). Incidence of Atrial Fibrillation as the Initial Manifestation of Cardiac Sarcoidosis: Insights From a Catheter Ablation Registry. CJC Open. 5(7). 577–584.
3.
Weng, Willy, Pascal Thériault-Lauzier, David H. Birnie, et al.. (2022). Should they stay, or should they go: Do we need to remove the old cardiac implantable electronic device if a new system is required on the contralateral side?. Heart Rhythm O2. 3(2). 169–175. 2 indexed citations
4.
Weng, Willy, Rob Beanlands, Pablo B. Nery, et al.. (2022). Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study. SHILAP Revista de lepidopterología. 24. 100224–100224. 6 indexed citations
5.
Parlow, Simon, Willy Weng, Pietro Di Santo, et al.. (2022). Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial. Canadian Journal of Cardiology. 38(8). 1211–1219. 13 indexed citations
6.
Weng, Willy, David H. Birnie, F. Daniel Ramirez, et al.. (2022). Outcomes of a comprehensive strategy during repeat atrial fibrillation ablation. Journal of Interventional Cardiac Electrophysiology. 65(2). 391–399. 9 indexed citations
7.
Jung, Richard G., Pietro Di Santo, Rebecca Mathew, et al.. (2022). Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial. Canadian Journal of Cardiology. 39(4). 394–402. 2 indexed citations
8.
Weng, Willy, Rajin Choudhury, John L. Sapp, et al.. (2021). The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial. BMC Cardiovascular Disorders. 21(1). 445–445. 5 indexed citations
9.
Weng, Willy, F. Daniel Ramirez, David H. Birnie, et al.. (2021). OUTCOMES OF A COMPREHENSIVE STRATEGY DURING REPEAT ATRIAL FIBRILLATION ABLATION. Canadian Journal of Cardiology. 37(10). S43–S43. 3 indexed citations
10.
Weng, Willy, Chris M. Blanchard, Jennifer L. Reed, et al.. (2020). A virtual platform to deliver ambulatory care for patients with atrial fibrillation. SHILAP Revista de lepidopterología. 2(1). 63–70. 8 indexed citations
11.
Weng, Willy, Santabhanu Chakrabarti, Pablo B. Nery, et al.. (2020). Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes. Journal of the American Heart Association. 9(17). e017086–e017086. 17 indexed citations
12.
Weng, Willy, et al.. (2020). Teaching Point-of-Care Ultrasound in Medicine. 15(2). 12–29. 11 indexed citations
13.
Mathew, Rebecca, Pietro Di Santo, Jeffrey A. Marbach, et al.. (2020). Abstract 125: Capital Do-Re-Mi: A Randomized Trial of Dobutamine Compared to Milrinone in Cardiogenic Shock. Circulation. 142(Suppl_4). 3 indexed citations
14.
Weng, Willy, John L. Sapp, Steve Doucette, et al.. (2017). Benefit of Implantable Cardioverter-Defibrillator Generator Replacement in a Primary Prevention Population-Based Cohort. JACC. Clinical electrophysiology. 3(10). 1180–1189. 10 indexed citations
17.
Gurbel, Paul A., Kevin P. Bliden, Joseph DiChiara, et al.. (2007). Evaluation of Dose-Related Effects of Aspirin on Platelet Function. Circulation. 115(25). 3156–3164. 313 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026